To illustrate how inappropriate the use of these studies are to draw conclusions about the effectiveness of e-cigarettes for smoking cessation, let's look at two of these studies:

Well, Polosa et al. have conducted exactly such a . They examined the changes in asthma symptoms among smokers who continue to smoke versus those who switch to electronic cigarettes. These investigators reported that in contrast to real cigarettes, the fake ones result in actual harm reversal. Lung function, asthma control, and asthma symptoms were significantly improved among patients who switched from regular cigarettes to electronic cigarettes. These improvements were even observed among patients who became dual users of both real and fake cigarettes.

It is also important to mention that banning electronic cigarette advertising would violate the First Amendment rights of e-cigarette companies.

"The FDA erred in concluding that current, ongoing financial relationships with drug manufacturers did not constitute a conflict. Since manufacturers of smoking-cessation drugs compete with manufacturers of DTPs, ... and since Dr. Benowitz stood to profit from the sale of NRT drugs, he faced a conflict with regard to providing advice in the TPSAC's report on DTPs. ... the TPSAC was charged with studying the public health impact of a drug (i.e., DTPs), and Dr. Benowitz had an ongoing business relationship (i.e., consulting work) with companies developing "alternative" or competing drugs (i.e., smoking-cessation drugs). Accordingly, I find that the FDA's conclusion with regard to Dr. Benowitz was a 'clear error of judgment.'"

LAST：2014 newest variable voltage mod with replaceable battery part |NEXT：2013 best-selling e-cigarette, amanoo orignal magnet e-cig,pcc e-cigarette